Using a robotic system for less invasive abdominal and pelvic surgeries

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase II trial evaluates the safety and effectiveness of the da Vinci single port robotic device (SP1098) for performing abdominal and pelvic surgeries. The device allows surgeons to conduct complex procedures through a single small incision, potentially leading to less pain, fewer complications, and improved recovery times for patients. Participants will undergo surgery using this robotic system, which is FDA-approved for other surgical indications. The study aims to gather data on the outcomes of these procedures compared to traditional methods.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Documented informed consent of the participant and/or legally authorized representative
* Any patient scheduled to undergo robot-assisted abdominal or pelvic procedures
* Age \> 18 years

Exclusion Criteria:

* Body mass index (BMI) \> 45
* Contraindications to minimally invasive surgery including chronic obstructive pulmonary disorders
* Past history of failed attempt of minimally invasive abdominal or pelvic surgery

Where it's running

• City of Hope Comprehensive Cancer Center
  Duarte, California, United States Recruiting

Study contacts

• Principal investigator: Mehdi Moslemi-Kebria — City of Hope Medical Center

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercise after pelvic radiation to see if it lowers colorectal cancer risk

  This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.

  Recruiting at 2 sites City of Hope Medical Center · Duarte, California and 1 other locations · NCT07790718

• Tear Fluid for Detecting Tumor-Linked Particles in Glioblastoma

  This study tests whether tear fluid can reveal tumor-associated particles in people with glioblastoma, potentially offering a easier way to monitor the cancer.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07775534

• Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression

  This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.

  Recruiting at 11 sites City of Hope Medical Center · Arcadia, California and 10 other locations · NCT07741968

• Mindfulness program to help with symptoms in chronic graft-versus-host disease

  A mindfulness-based program is being tested to see if it can reduce patient-reported symptoms for adults with chronic graft-versus-host disease after a stem cell transplant.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07733141

• Sacral Reflex Monitoring During Surgery to Predict Postoperative Function

  This study tests whether watching sacral nerve reflexes during sacrectomy or related spine surgeries can help predict how a patient will function after surgery.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07707024

• Belinostat combined with azacitidine or pralatrexate for relapsed or refractory TFH/Nodal PTCL and related T-cell lymphomas

  This early-phase trial tests whether adding belinostat to azacitidine or pralatrexate is safe and may help treat adults with relapsed or refractory follicular helper T-cell lymphoma and related T-cell cancers.

  Recruiting at 2 sites Phase 1 City of Hope Medical Center · Duarte, California and 1 other locations · NCT07691450

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.